Your browser doesn't support javascript.
loading
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.
Faridar, Alireza; Eid, Abdulmunaim M; Thome, Aaron D; Zhao, Weihua; Beers, David R; Pascual, Maria B; Nakawah, Mohammad O; Roman, Gustavo C; Davis, Charles S; Grundman, Michael; Masdeu, Joseph C; Appel, Stanley H.
Afiliación
  • Faridar A; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Eid AM; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Thome AD; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Zhao W; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Beers DR; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Pascual MB; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Nakawah MO; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Roman GC; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
  • Davis CS; CSD Biostatistics, Inc., Oro Valley, AZ, USA.
  • Grundman M; Global R&D Partners, LLC, San Diego, CA, USA.
  • Masdeu JC; University of California San Diego, San Diego, CA, USA.
  • Appel SH; Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, 6565 Fannin Street, Suite P3-201, Houston, TX, USA.
Transl Neurodegener ; 12(1): 54, 2023 11 16.
Article en En | MEDLINE | ID: mdl-37968718

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Transl Neurodegener Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Transl Neurodegener Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos